A 2019 clinical study followed 29 hallux toenails with a confirmed diagnosis of distal subungual onychomycosis. Mean patient age was 57. Patients received the ToeFX treatment every 2 weeks for 8 treatments, with follow-up treatments every 5 weeks thereafter until 6 months.
95% of patients responded to the treatment, showing improvement in clear nail.
70% of patients showed excellent or total clearance of the nail in 4-6 months.
Date of clinical trial approval: 2019
Principal Investigator: Dr. Alexander Rabinovich, MD FRSC
Site location: Hamilton, Canada